A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 31/16 (2006.01) A61K 31/381 (2006.01) A61K 38/18 (2006.01) A61K 38/48 (2006.01) A61K 38/55 (2006.01) C07K 16/28 (2006.01)
Patent
CA 2477932
The present invention relates to the use of a compound which is capable of inhibiting activation of a growth factor receptor of the EGFR-family for the prevention or treatment of processes associated with increased G-protein mediated signal transduction.
L'invention porte sur l'utilisation d'un composé capable d'inhiber l'activation d'un récepteur du facteur de croissance de la famille des EGFR pour la prévention ou le traitement de processus associés à un accroissement de la transduction de signaux médié par la protéine G.
Fischer Oliver
Gschwind Andreas
Leserer Michael
Schafer Beatrix
Ullrich Axel
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.v.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Use of egfr transactivation inhibitors in human cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of egfr transactivation inhibitors in human cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of egfr transactivation inhibitors in human cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1589965